United Health Products, Inc. (UEEC)
USD 0.25
(-0.04%)
USD 0.25
(-0.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.42 Million USD | 13.4% |
| 2022 | -2.8 Million USD | 90.6% |
| 2021 | -29.8 Million USD | -100.7% |
| 2020 | -14.84 Million USD | -143.66% |
| 2019 | -6.09 Million USD | -156.32% |
| 2018 | -2.37 Million USD | -230.53% |
| 2017 | -719.31 Thousand USD | -39.01% |
| 2016 | -517.47 Thousand USD | 79.96% |
| 2015 | -2.58 Million USD | -23.45% |
| 2014 | -2.09 Million USD | -58.9% |
| 2013 | -1.31 Million USD | -536.04% |
| 2012 | -207.01 Thousand USD | 84.29% |
| 2011 | -1.31 Million USD | 49.99% |
| 2010 | -2.63 Million USD | -397.26% |
| 2009 | -529.79 Thousand USD | -91.48% |
| 2008 | -276.68 Thousand USD | -21.21% |
| 2007 | -228.26 Thousand USD | -19.41% |
| 2006 | -191.16 Thousand USD | -1133.21% |
| 2005 | -15.5 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -425.09 Thousand USD | 4.83% |
| 2024 Q2 | -405.18 Thousand USD | 4.68% |
| 2023 FY | -2.42 Million USD | 13.4% |
| 2023 Q1 | -1.05 Million USD | -90.4% |
| 2023 Q2 | -475.45 Thousand USD | 54.89% |
| 2023 Q3 | -450.45 Thousand USD | 5.26% |
| 2023 Q4 | -446.66 Thousand USD | 0.84% |
| 2022 Q4 | -553.56 Thousand USD | -164.08% |
| 2022 Q1 | -954.5 Thousand USD | 10.87% |
| 2022 Q2 | -754.79 Thousand USD | 20.92% |
| 2022 Q3 | 863.8 Thousand USD | 214.44% |
| 2022 FY | -2.8 Million USD | 90.6% |
| 2021 Q1 | -26.7 Million USD | -497.28% |
| 2021 FY | -29.8 Million USD | -100.7% |
| 2021 Q4 | -1.07 Million USD | -47.84% |
| 2021 Q3 | -724.41 Thousand USD | 44.28% |
| 2021 Q2 | -1.3 Million USD | 95.13% |
| 2020 FY | -14.84 Million USD | -143.66% |
| 2020 Q4 | -4.47 Million USD | 50.9% |
| 2020 Q3 | -9.1 Million USD | -1305.48% |
| 2020 Q2 | -647.87 Thousand USD | -3.86% |
| 2020 Q1 | -623.8 Thousand USD | 70.51% |
| 2019 FY | -6.09 Million USD | -156.32% |
| 2019 Q1 | -2.98 Million USD | -324.25% |
| 2019 Q4 | -2.11 Million USD | -384.45% |
| 2019 Q3 | -436.66 Thousand USD | 21.48% |
| 2019 Q2 | -556.11 Thousand USD | 81.38% |
| 2018 FY | -2.37 Million USD | -230.53% |
| 2018 Q4 | -703.8 Thousand USD | -76.93% |
| 2018 Q1 | -357.54 Thousand USD | 33.42% |
| 2018 Q2 | -918.43 Thousand USD | -156.88% |
| 2018 Q3 | -397.79 Thousand USD | 56.69% |
| 2017 Q4 | -537.03 Thousand USD | -296.31% |
| 2017 Q3 | -135.5 Thousand USD | -24.58% |
| 2017 Q2 | -108.76 Thousand USD | -275.45% |
| 2017 FY | -719.31 Thousand USD | -39.01% |
| 2017 Q1 | 61.99 Thousand USD | 135.14% |
| 2016 Q1 | -111.78 Thousand USD | 76.15% |
| 2016 Q3 | -170.78 Thousand USD | -192.03% |
| 2016 Q4 | -176.41 Thousand USD | -3.3% |
| 2016 FY | -517.47 Thousand USD | 79.96% |
| 2016 Q2 | -58.48 Thousand USD | 47.69% |
| 2015 Q1 | -1.57 Million USD | 6.0% |
| 2015 FY | -2.58 Million USD | -23.45% |
| 2015 Q4 | -468.66 Thousand USD | -18.77% |
| 2015 Q3 | -394.6 Thousand USD | -166.72% |
| 2015 Q2 | -147.94 Thousand USD | 90.59% |
| 2014 Q2 | -198.5 Thousand USD | -33.06% |
| 2014 Q4 | -1.67 Million USD | -2198.59% |
| 2014 Q3 | -72.73 Thousand USD | 63.36% |
| 2014 FY | -2.09 Million USD | -58.9% |
| 2014 Q1 | -149.18 Thousand USD | 58.69% |
| 2013 Q2 | -85.35 Thousand USD | -113.1% |
| 2013 Q1 | -40.05 Thousand USD | 49.97% |
| 2013 Q4 | -361.16 Thousand USD | 56.46% |
| 2013 Q3 | -829.57 Thousand USD | -871.96% |
| 2013 FY | -1.31 Million USD | -536.04% |
| 2012 Q3 | -40 Thousand USD | 4.2% |
| 2012 FY | -207.01 Thousand USD | 84.29% |
| 2012 Q4 | -80.05 Thousand USD | -100.1% |
| 2012 Q2 | -41.75 Thousand USD | 7.62% |
| 2012 Q1 | -45.2 Thousand USD | 86.63% |
| 2011 Q3 | -190.25 Thousand USD | 19.92% |
| 2011 FY | -1.31 Million USD | 49.99% |
| 2011 Q1 | -551.6 Thousand USD | -102.32% |
| 2011 Q2 | -237.56 Thousand USD | 56.93% |
| 2011 Q4 | -337.98 Thousand USD | -77.65% |
| 2010 Q4 | -272.63 Thousand USD | 74.23% |
| 2010 Q3 | -1.05 Million USD | 11.71% |
| 2010 Q2 | -1.19 Million USD | -1036.75% |
| 2010 Q1 | -105.42 Thousand USD | 68.62% |
| 2010 FY | -2.63 Million USD | -397.26% |
| 2009 Q1 | -74.3 Thousand USD | 17.31% |
| 2009 FY | -529.79 Thousand USD | -91.48% |
| 2009 Q4 | -335.99 Thousand USD | -626.71% |
| 2009 Q3 | 63.79 Thousand USD | 135.79% |
| 2009 Q2 | -178.23 Thousand USD | -139.86% |
| 2008 Q4 | -89.85 Thousand USD | 29.18% |
| 2008 Q2 | -28.87 Thousand USD | 1.47% |
| 2008 Q3 | -126.88 Thousand USD | -339.44% |
| 2008 Q1 | -29.3 Thousand USD | 20.82% |
| 2008 FY | -276.68 Thousand USD | -21.21% |
| 2007 Q2 | -67.61 Thousand USD | 14.03% |
| 2007 FY | -228.26 Thousand USD | -19.41% |
| 2007 Q3 | -55.38 Thousand USD | 18.09% |
| 2007 Q1 | -78.65 Thousand USD | -74.03% |
| 2007 Q4 | -37.01 Thousand USD | 33.18% |
| 2006 Q1 | -20.95 Thousand USD | -184.95% |
| 2006 Q3 | -61.71 Thousand USD | 2.25% |
| 2006 Q4 | -45.19 Thousand USD | 26.77% |
| 2006 FY | -191.16 Thousand USD | -1133.21% |
| 2006 Q2 | -63.13 Thousand USD | -201.22% |
| 2005 Q4 | -7355.00 USD | -45.3% |
| 2005 Q3 | -5062.00 USD | 0.0% |
| 2005 FY | -15.5 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 308.426% |
| Ansell Limited | 129.3 Million USD | 101.877% |
| Ansell Limited | 129.3 Million USD | 101.877% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 107.793% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -52.067% |
| Psykey, Inc. | -797.5 Thousand USD | -204.267% |
| ConvaTec Group Plc | 262.7 Million USD | 100.924% |
| ConvaTec Group Plc | 262.7 Million USD | 100.924% |
| Encision Inc. | -640.78 Thousand USD | -278.683% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1611.12% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -2107.349% |
| Innovative MedTech Inc. | -4.27 Million USD | 43.227% |
| LifePoint, Inc. | -7.49 Million USD | 67.626% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 62.553% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 835.315% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -1874.562% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -419.292% |
| SmileDirectClub, Inc. | -241.15 Million USD | 98.994% |
| Sector 10, Inc. | -39.84 Thousand USD | -5990.099% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.759% |
| SheerVision, Inc. | 155.72 Thousand USD | 1658.211% |
| Vasamed, Inc. | 4.74 Million USD | 151.168% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | -5.771% |
| Yubo International Biotech Limited | -1.2 Million USD | -101.335% |